InfuSystem Holdings, Inc. (INFU) financial statements and ratios from SEC XBRL: revenue $143.44M (TTM), net margin 4.6%, revenue growth 2.6% YoY, P/E 28.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $143.44M |
| Net Margin | 4.6% |
| Revenue Growth (YoY) | 2.6% |
| EPS Growth (YoY) | 33.3% |
| FCF Growth (YoY) | -1.6% |
| P/E Ratio | 28.4 |
| EV / EBITDA | 10.0 |
| Price / Book | 4.10 |
| Price / Sales | 1.69 |
| FCF Yield | 9.4% |
| DCF Value (model) | $4.62 |
| DCF Upside vs Price | -62.1% |
| Altman Z-Score | 4.58 (safe) |
| Piotroski F-Score | 8/9 |
| Sector P/E (Healthcare) | 21.6 |
INFU overview · INFU earnings · INFU KPIs · INFU investor relations · INFU ownership · INFU peers · INFU filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.